AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,462 | +13.9% | 164 | +17.1% | 0.00% | 0.0% |
| Q2 2023 | $10,061 | +20.8% | 140 | +3.7% | 0.00% | 0.0% |
| Q1 2023 | $8,327 | -20.0% | 135 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $10,413 | +73.6% | 135 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $6,000 | +20.0% | 135 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $5,000 | +66.7% | 135 | +107.7% | 0.00% | – |
| Q1 2022 | $3,000 | -62.5% | 65 | -68.6% | 0.00% | -100.0% |
| Q4 2021 | $8,000 | +14.3% | 207 | +3.5% | 0.00% | 0.0% |
| Q3 2021 | $7,000 | 0.0% | 200 | +85.2% | 0.00% | 0.0% |
| Q2 2021 | $7,000 | +16.7% | 108 | -2.7% | 0.00% | 0.0% |
| Q1 2021 | $6,000 | -25.0% | 111 | +11.0% | 0.00% | 0.0% |
| Q4 2020 | $8,000 | +14.3% | 100 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $7,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |